Inventors scoop European awards

June 14, 2012
Inventors of a new drug for hepatitis B treatment, a tailor-made hearing aid and improved high speed data transfer were awarded a coveted European Patent Office prize.

Inventors of a new drug for hepatitis B treatment, a tailor-made hearing aid and improved high speed data transfer were awarded a coveted European Patent Office prize here Thursday.

In the research category French scientist Gilles Gosselin, and his co-inventors Jean-Louis Imbach, also of France, and the late US professor Martin L. Bryant won the prize for developing "a highly effective anti-viral drug against hepatitis B".

The new drug shows less cross-resistance with other medications and can thus be used as a first line of treatment, the (EPO) said.

One hundred times more infectious than the that causes AIDS, (HBV) is a particularly persistent disease that chronically affects 350 million people worldwide, despite the availability of vaccines.

Some two billion people have been infected worldwide with HBV.

The EPO's Inventor Award in the category Industry went to Danish scientists Jan Toepholm, Soeren Westermann and Svend Vitting Andersen for developing a tailor-made hearing aid after becoming aware of the drawbacks of traditional hearing-aid design.

In the category Non-European countries the winners were Australians John O' Sullivan, Graham Daniels, Terence Percival, Diethelm Ostry and John Deane, of the Commonwealth Scientific and Industrial Research Organisation, for developing a wireless LAN (local area network) for transfer.

The winner of the European Inventor Award 2012 in the category Lifetime Achievement, German Professor Josef Bille of Heidelberg University, was rewarded for developing a device for .

Bille has filed almost 100 patents in the field of ophthalmology and is a pioneer in the area of laser eye correction.

The Munich-based European Patent Office launched the award in 2006.

Explore further: Patent fight in India centers on AIDS drug

Related Stories

European office withdraws Nexium patent

December 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

EU gives green light for while-you-wait hepatitis B test

May 18, 2010

An inexpensive new test for the detection of Hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accurate results while-you-wait, ...

Google signs deal to translate European patents

November 30, 2010

(AP) -- Google announced an agreement Tuesday to use its technology to translate patents into 29 European languages, a deal officials hope will smooth the way toward a simplified European patent system after years of infighting.

Recommended for you

Chimpanzees shed light on origins of human walking

October 6, 2015

A research team led by Stony Brook University investigating human and chimpanzee locomotion have uncovered unexpected similarities in the way the two species use their upper body during two-legged walking. The results, reported ...

How much for that Nobel prize in the window?

October 3, 2015

No need to make peace in the Middle East, resolve one of science's great mysteries or pen a masterpiece: the easiest way to get yourself a Nobel prize may be to buy one.

The dark side of Nobel prizewinning research

October 4, 2015

Think of the Nobel prizes and you think of groundbreaking research bettering mankind, but the awards have also honoured some quite unhumanitarian inventions such as chemical weapons, DDT and lobotomies.

Who you gonna trust? How power affects our faith in others

October 6, 2015

One of the ongoing themes of the current presidential campaign is that Americans are becoming increasingly distrustful of those who walk the corridors of power – Exhibit A being the Republican presidential primary, in which ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.